Palisade Bio (PALI) Net Income towards Common Stockholders (QoQ) (2010 - 2026)
Palisade Bio (PALI) Net Income towards Common Stockholders (QoQ) (2010 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
| 10 |
Palisade Bio |
357.48 Mn |
227.91 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
-7.67% |
| Dec 31, 2025 |
-248.08% |
| Sep 30, 2025 |
-3.02% |
| Jun 30, 2025 |
-24.84% |
| Mar 31, 2025 |
34.12% |
| Dec 31, 2024 |
2.93% |
| Sep 30, 2024 |
14.53% |
| Jun 30, 2024 |
-15.68% |
| Mar 31, 2024 |
-11.68% |
| Dec 31, 2023 |
16.59% |
| Sep 30, 2023 |
-11.58% |
| Jun 30, 2023 |
-45.00% |
| Mar 31, 2023 |
39.24% |
| Dec 31, 2022 |
12.81% |
| Sep 30, 2022 |
-88.44% |
| Jun 30, 2022 |
39.73% |
| Mar 31, 2022 |
-162.81% |
| Dec 31, 2021 |
20.96% |
| Sep 30, 2021 |
116.12% |
| Jun 30, 2021 |
-767.12% |
